Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DR26FHY2Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $82,109
Award facts
- Contract value 100% obligated
- $82,108.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $82,108.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg dose in 2 pen/mL formulation. This award, issued on October 28, 2025, with completion targeted for October 29, 2025, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania.
This delivery order supports the Defense Health Agency's medical supply requirements as part of AmerisourceBergen's comprehensive pharmaceutical distribution role. AmerisourceBergen maintains a $999,999,999 IDC with DLA Troop Support Medical (designated SPE2DX) running through December 2026, which serves as the underlying contract vehicle enabling procurement of a broad range of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs globally. Cosentyx is a biologic immunosuppressant used to treat autoimmune conditions, and this order contributes to ensuring adequate pharmaceutical inventory for federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FHY2Q?
SPE2DR26FHY2Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26FHY2Q worth?
The government has obligated $82,109 on SPE2DR26FHY2Q.
Is contract SPE2DR26FHY2Q an order under another contract?
Yes. SPE2DR26FHY2Q is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FHY2Q competed?
The extent of competition for SPE2DR26FHY2Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award